SORT1 and breast cancer: Finally, immunohistochemistry experiments performed in a cohort of clinical breast cancers and normal breast tissues revealed an increase in the expression of Sortilin/NTSR3 associated with breast cancer aggressiveness, particularly in ductal invasive carcinomas and in association with lymph node invasion [23].